Less access to care and lower insurance coverage are among the reasons for racial disparities in breast cancer survival in the United States. Eligible beneficiaries in the US Military Health System have insurance and access to care. This study examined whether racial differences existed in time to surgery and whether any differences in that time might explain racial disparities in overall survival between nearly 1,000 black and 3,900 white women diagnosed with breast cancer in the Military Health System.
Scientists at the University of Edinburgh have identified genetic changes that may predict the likelihood of breast cancer relapse in women taking a common type of hormone therapy.
A new study finds acupressure could be a low-cost, at-home solution to a suite of persistent side effects that linger after breast cancer treatment ends.
Breast cancers diagnosed in young women within 10 years of giving birth are more likely to metastasize, and thus more likely to cause death, than breast cancers in young women who gave birth less recently or not at all.
Cancers most commonly arise because of a series of two to five mutations in different genes that combine to cause a tumor. Evidence from a growing number of experiments focused on truncal mutations -- the first mutations in a given sequence -- suggests a new direction in understanding the origins of cancer.
Scientists have created the most comprehensive method yet to predict a woman's risk of breast cancer, according to a study by Cancer Research UK published in Genetics in Medicine.
African-American women at high risk of breast cancer are less likely than white women to pursue potentially life-saving preventive care, and racial disparities in health care and elsewhere are to blame, new research suggests.
An innovative combination therapy can force malignant breast cancer cells to turn into fat cells. This can be used to prevent the formation of metastases in mice, as researchers at the University of Basel's Department of Biomedicine recently reported in the journal Cancer Cell.
As cancer cells respond to cues in their microenvironment, they can enter a highly plastic state in which they are susceptible to transdifferentiation into a different type of cell. Researchers at the University of Basel in Switzerland exploited this critical phase, known as an epithelial-mesenchymal transition (EMT), to coax breast cancer cells in mice to turn into harmless fat cells. The proof-of-concept study appears Jan. 14, 2019, in the journal Cancer Cell.
Research led by Suresh Alahari, PhD, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health New Orleans School of Medicine, has found a new role for a protein discovered by his lab in preventing the growth and spread of breast cancer.